Recent 8-K filings for SGRY

• May 5, 2026, 7:59 PM ET earnings materiality 0.60 neutral item 2.02item 9.01 ◈ Earnings Releases ×2

  Surgery Partners Q1 revenue $810.9M (+4.5%), net loss $35.9M; reaffirms FY guidance

  Revenue $810.9M (+4.5% YoY); same-facility revenue +4.4% on 0.6% case growth and 3.8% revenue per case.

• March 2, 2026, 6:59 PM ET earnings materiality 0.75 negative item 2.02item 7.01item 9.01

  Surgery Partners Q4 rev $885M (+2.4%), Adj. EBITDA $156.9M (-4.2%), net loss $15M, 2026 guidance, $200M buyback

  Revenue $885.0M (+2.4% YoY); full-year $3.3B (+6.2%). Same-facility revenue +3.5% Q4.

• December 11, 2025, 6:59 PM ET debt materiality 0.60 neutral item 7.01item 9.01

  Surgery Partners subsidiary to offer $425M add-on 7.250% senior notes due 2032

  Intent to offer $425M additional 7.250% Senior Notes due 2032, same series as April 2024 issuance.

• November 12, 2025, 6:59 PM ET leadership materiality 0.60 neutral item 5.02item 9.01

  Surgery Partners appoints Justin Oppenheimer as COO and National Group President effective Jan 1, 2026

  Oppenheimer joins from Hospital for Special Surgery, where he was Chief Strategy Officer and COO.

• November 10, 2025, 6:59 PM ET earnings materiality 0.70 negative item 2.02item 9.01

  Surgery Partners Q3 revenue up 6.6% to $821.5M, net loss $22.7M; FY guidance cut

  Revenue $821.5M (+6.6% YoY); same-facility revenue +6.3%, cases +3.4%.

• August 13, 2025, 7:59 PM ET debt materiality 0.60 neutral item 1.01item 2.03item 9.01 ◈ Debt Financings

  Surgery Partners closes $1.383B term loan refinancing; extends maturities to 2030/2028

  New $1.383B 2025 Refinancing Term Loans replace existing term loans; maturity extended to Dec 19, 2030.

• August 6, 2025, 7:59 PM ET leadership materiality 0.60 neutral item 5.02

  Surgery Partners Chairman Wayne DeVeydt resigns; Blair Hendrix named new Chairman

  Wayne S. DeVeydt resigned as director and Executive Chairman effective August 4, 2025.

• August 5, 2025, 7:59 PM ET earnings materiality 0.65 positive item 2.02item 9.01

  Surgery Partners Q2 revenue up 8.4% to $826.2M; Adj EBITDA $129M, up 9%; reaffirms FY2025 guidance

  Revenue $826.2M (+8.4% YoY); same-facility revenue +5.1%, same-facility cases +3.4%.

• June 17, 2025, 7:59 PM ET other material materiality 0.75 neutral item 7.01item 9.01

  Surgery Partners ends Bain Capital buyout talks; reaffirms 2025 guidance

  Special Committee determined that remaining independent provides greater long-term value than Bain Capital's acquisition proposal.

• May 12, 2025, 7:59 PM ET earnings materiality 0.60 neutral item 2.02item 9.01

  Surgery Partners Q1 revenue up 8.2% to $776M; Adj EBITDA $103.9M (+6.6%); net loss $37.7M

  Same-facility revenue +5.2%, same-facility cases +6.5% YoY; revenue per case -1.2%.

• March 3, 2025, 6:59 PM ET earnings materiality 0.75 positive item 2.02item 9.01

  Surgery Partners Q4 revenue up 17.5% to $864.4M; Adj EBITDA +15.1%; sets 2025 guidance

  Q4 revenue $864.4M (+17.5% YoY); full-year revenue $3.1B (+13.5% YoY).

• January 28, 2025, 6:59 PM ET M&A materiality 0.85 neutral item 8.01item 9.01

  Surgery Partners receives $25.75/share buyout proposal from Bain Capital; Bain owns ~39%

  Bain Capital proposes to acquire all outstanding shares not already owned for $25.75 per share in cash.

• November 12, 2024, 6:59 PM ET earnings materiality 0.75 positive item 2.02item 9.01

  Surgery Partners Q3 revenue $770.4M (+14.3% YoY); adjusted EBITDA $128.6M (+21.9%)

  Revenue $770.4M, +14.3% YoY; same-facility revenue +4.2% on 3.7% case growth.

• August 6, 2024, 7:59 PM ET earnings materiality 0.80 positive item 2.02item 9.01

  Surgery Partners Q2 revenue +14.2% to $762.1M; raises FY2024 guidance

  Revenue $762.1M (+14.2% YoY); same-facility revenue up 9.9%, cases up 3.9%.

• May 7, 2024, 7:59 PM ET earnings materiality 0.75 positive item 2.02item 9.01 ◈ Earnings Releases ×2

  Surgery Partners Q1 revenue up 7.7% to $717.4M, Adjusted EBITDA $97.5M; raises FY outlook

  Net loss $12.4M; Adjusted EBITDA $97.5M (+8.2% YoY); margin 13.6%.

Earnings & guidance

Materiality & sentiment trend

Max materiality 0.85 · Median 0.60 · Most common event earnings

5 positive 2 negative 16 neutral

source · SGRY on sec.gov